logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Mihaela Aldea

Dana-Farber Cancer Institute
H指数:24
被引数:2,570

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biology

重新定义胸腺上皮肿瘤的治疗前景：精准治疗、联合疗法及新兴生物学

npj Precision Oncology
IF8
2026-06-260
OAAI
Jennifer A. Marks; Rohan Maniar; Kavitha J. Ramchandran; Erica Pietroluongo; Mehmet Altan; Surbhi Singhal; Mihaela Aldea; Jonathan W. Goldman; Jonathan W. Reiss; Heather Wakelee; Patrick J. Loehrer; Marina Chiara Garassino; Anja C. Roden; Jordi Remon; Christopher S. Nabel; Chul Kim
Efficacy of Alectinib for ALK-positive NSCLC According to Tumor Burden and Body Mass Index: a Pooled Analysis of the Randomized Phase III Trials ALEX and J-ALEX

根据肿瘤负荷和体重指数评估阿来替尼对ALK阳性NSCLC的疗效：ALEX和J-ALEX随机III期试验的合并分析

European Journal of Cancer
IF7.1
2026-06-050
OAAI
Marco Tagliamento; Marco Bruzzone; Eva Blondeaux; Filippo Dall’Olio; Mihaela Aldea; Carlo Genova; Arianna Marinello; Jordi Remon; Lizza E.L. Hendriks; Lucia Del Mastro; David Planchard; Fabrice Barlesi; Matteo Lambertini; Benjamin Besse
Sex-based differences in tolerability of developmental antibody-drug conjugates (ADCs) in non-small-cell lung cancer (NSCLC)

性别在非小细胞肺癌（NSCLC）中对处于研发阶段的抗体药物偶联物（ADCs）耐受性的差异

ESMO Open
IF8.3
2026-06-012
OAAI
Parisi, C.; Banini, M.; Mantuano, F.; Aldea, M.; Abdayem, P.; Derosa, L.; Frelaut, M.; Lavaud, P.; Robert, A.; Simon, S.; Gazzah, A.; Hollebecque, A.; Massard, C.; Besse, B.; Remon, J.; Wagner, A.; Pistilli, B.; Vaz-Luis, I.; Planchard, D.; Barlesi, F.
Next-Generation Multicenter Studies: Using Artificial Intelligence to Automatically Process Unstructured Health Records of Patients with Lung Cancer across Multiple Institutions

下一代多中心研究：利用人工智能自动处理跨机构肺癌患者的非结构化健康记录

Annals of Oncology
IF65.4
2025-12-150
PRE
M. Aldea; L. Zullo; V. Levrat; J. Bennouna; S. Schneider; O. Mercier; E. Mougenot; E. Bergot; C. Dujon; N. Cloarec; C.Audigier Valette; A. Nuccio; M. Deloger; C. Helissey; S. Simon; A. Carpentier; A. Djarallah; P. Rolland; J.C. Louis; L. Ancillon
Comprehensive molecular landscape of anal squamous cell carcinoma: analysis of tissue and liquid biopsies from 1844 patients

肛门鳞状细胞癌的全面分子图谱：1844例患者的组织活检和液体活检分析

npj Precision Oncology
IF8
2025-11-240
OAAI
Cristina Smolenschi; Saumya D. Sisoudiya; Antoine Hollebecque; Smruthy Sivakumar; Meagan Montesion; Victor Euzen; Valérie Boige; Alice Boilève; Marine Valery; Isabelle Sourouille; Arnaud Bayle; Mihaela Aldea; Julieta Elena Rodriguez; Massimiliano Gelli; Filippo Gustavo Dall’Olio; Anthony Tarabay; Thomas Pudlarz; Rastislav Bahleda; Alina Fuerea; Léonor Benhaim; Elena Fernandez de Sevilla; Mohamed Bani; Peggy Dartigues; Simon Pernot; Gautier Boillet; Kristi Beshiri; Christophe Massard; Luc Friboulet; Francesco Facchinetti; Ludovic Lacroix; Etienne Rouleau; Fabrice Barlesi; Michel Ducreux; Antoine Italiano; Radwa Sharaf; Damien Vasseur
ESMO Basic Requirements for AI-based Biomarkers In Oncology (EBAI)

ESMO对基于AI的肿瘤学生物标志物的基本要求 (EBAI)

Annals of Oncology
IF65.4
2025-11-180
OAAI
M. Aldea; M. Salto-Tellez; A. Marra; R. Umeton; A. Stenzinger; M. Koopman; A. Prelaj; K.L. Kehl; S. Gilbert; M-E Leßmann; J. Lipkova; L. Provenzano; F. Meric-Bernstam; S. Halabi; J. Wu; A. Pellat; K.P.M. Suijkerbuijk; B. Besse; B. Ryll; C. Marchió
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50%

PD-L1 ≥50%的晚期非小细胞肺癌患者，在初次免疫治疗原发性耐药后，采用疾病进展后联合铂类为基础的化疗的免疫治疗。

ESMO Open
IF8.3
2025-11-170
OAAI
A. De Giglio; L. Zullo; A. Di Federico; M. Cani; M. Aldea; D. Soldato; F.G. Dall’Olio; F. Mantuano; F. Sperandi; V. Favorito; A. Sadowska; L.E.L. Hendriks; T. Gorria; L. Mezquita; F. Tabbò; S. Novello; F. Gelsomino; B. Besse; A. Ardizzoni
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study

一线免疫治疗联合或不联合化疗与BRAF联合MEK抑制剂在BRAFV600E突变型转移性非小细胞肺癌中的比较（FRONT-BRAF）：一项多中心、回顾性队列研究

The Lancet Oncology
IF0
2025-09-290
PRE
Alessandro Di Federico; Kaiwen Wang; Monica F Chen; Adam A Barsouk; Arianna Pagliaro; Lanyi N Chen; Francesca R Ogliari; Paul Stockhammer; Rajat Thawani; Shahm Raslan; Eleonora Gariazzo; Francesca Fusco; Grace M Hambelton; Fabrizio Citarella; David Meyer; Mihaela Aldea; Andrea De Giglio; Joao V Alessi; Federica Pecci; Francesco Gelsomino; Marcelo Corassa; Natalie I Vokes; Xinan Wang; Dario de Biase; Fawzi Abu Rous; Phurin Areesawangkit; Omar Elghawy; Alessio Cortellini; Giulio Metro; Roberto Ferrara; Mark M Awad; Aliyah Pabani; Joseph C Murray; Federico Cappuzzo; Marina C Garassino; Ibiayi Dagogo-Jack; Gregory Riely; Michael Grant; Benjamin O Herzberg; Andrea Ardizzoni; David Planchard; Bruce E Johnson; Corey J Langer; Michael Offin; Marcelo V Negrao; Biagio Ricciuti
The impact of dual cannabis and tobacco smoking in young patients with lung cancer: results from the prospective “Environment and Lung Cancer” study

年轻肺癌患者中双重吸食大麻和烟草的影响：来自前瞻性“环境与肺癌”研究的结果

CHEST
IF8.6
2025-09-240
PREAI
P. Pradère; A. Marinello; D. Vasseur; C. Naltet; S. Moaca; J. Le Pavec; M.R. Ghigna; V. De Montpreville; J. Adam; L. Lacroix; F. Ben Sallem; C. Caramella; D. Planchard; O. Mercier; M. Aldea; J.C. Alvarez
Brief Report: Critical Role for DNA-Based Sequencing in Discriminating Distinct Primary Lung Cancers with Different MET Exon 14 Skipping Mutations.

简报：DNA测序在区分具有不同MET外显子14跳跃突变的不同原发性肺癌中的关键作用。

Journal of Thoracic Oncology
IF20.8
2025-09-200
PRE
Federica Pecci; Prashasti Agrawal; Jessica S. Ross; Biagio Ricciuti; Seshiru Nakazawa; Alessandro Di Federico; Mihaela Aldea; Edoardo Garbo; Valentina Santo; Eleonora Gariazzo; Maisam Makarem; Danielle Haradon; Igor Odintsov; Marina Baine; William Travis; Soo-Ryum Yang; Paula A.Ugalde Figueroa; Katherine D. Gray; Mizuki Nishino; Maria Mayoral Penalva; Pasi A. Jänne; Lynette M. Sholl; Mark M. Awad; Jamie E. Chaft
Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survival

非小细胞肺癌患者新辅助化免疫治疗的实际结果：手术、病理完全缓解和事件无进展生存的预测因素

Cancer
IF5.1
2025-09-090
PRE
Alissa J. Cooper MD; Edoardo Garbo MD; Andrea Arfe PhD; Michael Conroy MB, BCh, Bao; Narek Shaverdian MD; Matthew Bott MD; Teresa Gorria MD; Federica Pecci MD; Mihaela Aldea MD, PhD; Valsamo Anagnostou MD, PhD; Adam Schoenfeld MD; Daniel Gomez MD, MBA; Patrick M. Forde MBBCh; Mark M. Awad MD, PhD; David R. Jones MD; Biagio Ricciuti MD, PhD; Jamie E. Chaft MD
Molecular Tumor Boards: A consensus statement from the International Association for the Study of Lung Cancer

分子肿瘤委员会：国际肺癌研究协会的共识声明

Journal of Thoracic Oncology
IF20.8
2025-07-070
PRE
Mihaela Aldea; Julia K. Rotow; Maria Arcila; Matthew Hatton; Lynette Sholl; Christian Rolfo; Marco Tagliamento; Teodora Radonic; Kurt A. Schalper; Vivek Subbiah; Umberto Malapelle; Anja C. Roden; Rami Manochakian; Ming-Sound Tsao; Helena Linardou; Rina Hui; Silvia Novello; Alastair Greystoke; Anjali Saqi; Sylvie Lantuejoul; David M. Hwang; Kelly Nevins; Murry Wynes; Saiama Waqar; Yuchen Han; Yasushi Yatabe; Wei-Chin Chang; Takuo Hayashi; Tae-Jung Kim; Paul Hofman; Fabio Tavora; Fred R. Hirsch; Valeria Denninghoff; Natasha B. Leighl; Alexander Drilon; Wendy A. Cooper; Sanja Dacic; Pranshu Mohindra; Nick Pavlakis; Fernando Lopez-Rios
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small cell lung cancer

DNA甲基转移酶3A（DNMT3A）突变与非小细胞肺癌中PD-(L)1阻断疗法的疗效

Annals of Oncology
IF65.4
2025-06-180
PRE
B. Ricciuti; S. Scalera; X. Wang; A. Elkrief; M. Tagliamento; E. Gariazzo; F. Paoloni; P.G. Miller; F. Pecci; A. Di Federico; V. Santo; J.V. Alessi; M. Aldea; E. Garbo; G. Lamberti; W. Zrafi; J.B. Micol; L.M. Sholl; M. Nishino; F. Cappuzzo; N. Calonaci; G. Caravagna; R. Ferrara; B. Besse; A. Schoenfeld; M. Maugeri-Sacca; M.M. Awad
AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors

AP1介导的EGFR表达重编程触发了RET易位肿瘤对BLU-667和LOXO-292的耐药性

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
IF12.8
2025-05-220
OA
Esposito, Daniela; Ascione, Claudia Maria; Belli, Stefania; Napolitano, Fabiana; Servetto, Alberto; Pepe, Felice; Malapelle, Umberto; Iaccarino, Antonino; Troncone, Giancarlo; Barone, Diletta; Bria, Emilio; Ferrara, Roberto; Lorenzini, Daniele; Lo Russo, Giuseppe; Ghigna, Maria Rosa; Marinello, Arianna; Aldea, Mihaela; Besse, Benjamin; Formisano, Luigi; Bianco, Roberto
Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLC

MET激酶域激活突变与其他驱动癌基因共发生，并介导非小细胞肺癌对靶向治疗的耐药性

Journal of Thoracic Oncology
IF20.8
2025-04-020
PRE
Seshiru Nakazawa; Federica Pecci; Biagio Ricciuti; Felix H. Gottlieb; Francesco Facchinetti; Guilherme Harada; Monica F. Chen; Matteo Repetto; Flavia Giacomini; Jie Jiang; Marie-Anaïs Locquet; Maisam Makarem; Joao V. Alessi; Alessandro Di Federico; Mihaela Aldea; Edoardo Garbo; Malini M. Gandhi; Arushi Saini; Danielle Haradon; Magda Bahcall; William W. Feng; Jessica K. Lee; Alexa B. Schrock; Alexander Drilon; Mark M. Awad; Pasi A. Jänne
Personalized Therapy in a Patient With EGFR- Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms

EGFR突变的NSCLC患者的个性化治疗发展序贯CCDC6-RET融合和BRAF V600E突变作为旁路耐药机制

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2025-03-010
OA
Marinello, Arianna; Parisi, Claudia; Vasseur, Damien; Combarel, David; Bihoreau, Juliette; Lavaud, Pernelle; Ezzedine, Remy; Zullo, Lodovica; Friboulet, Luc; Zalcman, Gerard; Italiano, Antoine; Besse, Benjamin; Aldea, Mihaela

研究方向

暂未获取到该数据
B
Benjamin Besse
H 指数:100论文数:1,844被引数:5.6万
D
David Planchard
H 指数:87论文数:989被引数:5.1万
F
Fabrice Barlési
H 指数:99论文数:1,480被引数:7.1万
D
Damien Vasseur
H 指数:13论文数:230被引数:625
A
Anas Gazzah
H 指数:34论文数:357被引数:7,968
M
Marco Tagliamento
H 指数:33论文数:192被引数:3,348
A
Antoîne Italiano
H 指数:99论文数:1,422被引数:4.5万
P
Pernelle Lavaud
H 指数:19论文数:324被引数:1,454
A
Antoine Hollebecque
H 指数:65论文数:987被引数:2.6万
A
Arianna Marinello
H 指数:9论文数:60被引数:312